Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: a systematic review and meta-analysis

EJ Lehrer, R Singh, M Wang, VM Chinchilli… - JAMA …, 2021 - jamanetwork.com
Importance The oligometastatic paradigm postulates that patients with a limited number of
metastases can be treated with ablative local therapy to each site of disease with curative …

The abscopal effect: a review of pre-clinical and clinical advances

JR Janopaul-Naylor, Y Shen, DC Qian… - International journal of …, 2021 - mdpi.com
Radiotherapy has been used for more than a hundred years to cure or locally control tumors.
Regression of tumors outside of the irradiated field was occasionally observed and is known …

Management of salivary gland malignancy: ASCO guideline

JL Geiger, N Ismaila, B Beadle, JJ Caudell… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE To provide evidence-based recommendations for practicing physicians and
other healthcare providers on the management of salivary gland malignancy. METHODS …

Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study

A Chalkidou, T Macmillan, MT Grzeda… - The lancet …, 2021 - thelancet.com
Background Stereotactic ablative body radiotherapy (SABR) is increasingly being used to
treat oligometastatic cancers, but high-level evidence to provide a basis for policy making is …

Single-fraction vs multifraction stereotactic ablative body radiotherapy for pulmonary oligometastases (SAFRON II): the trans tasman radiation oncology group 13.01 …

S Siva, M Bressel, T Mai, H Le, S Vinod… - JAMA …, 2021 - jamanetwork.com
Importance Evidence is lacking from randomized clinical trials to guide the optimal approach
for stereotactic ablative body radiotherapy (SABR) in patients with pulmonary …

Advances in breast cancer radiotherapy: implications for current and future practice

C Shah, Z Al-Hilli, F Vicini - JCO oncology practice, 2021 - ascopubs.org
Radiation therapy (RT) is an essential component in the management of breast cancer.
Following breast-conserving surgery (BCS), adjuvant RT is the standard of care for most …

Recurrent endometrial cancer: local and systemic treatment options

H Rütten, C Verhoef, WJ van Weelden, A Smits… - Cancers, 2021 - mdpi.com
Simple Summary In this review, we discuss the different treatment strategies in recurrent
endometrial cancer. The incidence of endometrial cancer is rising. The available treatment …

Biology-guided radiotherapy: redefining the role of radiotherapy in metastatic cancer

SM Shirvani, CJ Huntzinger, T Melcher… - The British journal of …, 2021 - academic.oup.com
The emerging biological understanding of metastatic cancer and proof-of-concept clinical
trials suggest that debulking all gross disease holds great promise for improving patient …

Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive framework

KS Saini, C Twelves - British Journal of Cancer, 2021 - nature.com
The complexity of neoplasia and its treatment are a challenge to the formulation of general
criteria that are applicable across solid cancers. Determining the number of prior lines of …

Organ at risk dose constraints in SABR: a systematic review of active clinical trials

SG Gerhard, DA Palma, AJ Arifin, AV Louie… - Practical radiation …, 2021 - Elsevier
Purpose Organ at risk (OAR) dose constraints are a critical aspect of SABR treatment
planning. There is limited evidence supporting preferred dose constraints for many OARs …